# New Analytic Tools for aHUS and C3G Diagnosis

> **NCT05985122** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Mario Negri Institute for Pharmacological Research** · enrollment: 180 (estimated)

## Conditions studied

- Hemolytic-Uremic Syndrome
- Membranoproliferative Glomerulonephritis
- Healthy

## Interventions

- **DIAGNOSTIC_TEST:** C3NEF assay

## Key facts

- **NCT ID:** NCT05985122
- **Lead sponsor:** Mario Negri Institute for Pharmacological Research
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-07-01
- **Primary completion:** 2026-10
- **Final completion:** 2026-10
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2026-03-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05985122

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05985122, "New Analytic Tools for aHUS and C3G Diagnosis". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05985122. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*